Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neuropsychopharmacology ; 47(7): 1387-1397, 2022 06.
Artigo em Inglês | MEDLINE | ID: mdl-34593976

RESUMO

Tianeptine is an atypical antidepressant used in Europe to treat patients who respond poorly to selective serotonin reuptake inhibitors (SSRIs). The recent discovery that tianeptine is a mu opioid receptor (MOR) agonist has provided a potential avenue for expanding our understanding of antidepressant treatment beyond the monoamine hypothesis. Thus, our studies aim to understand the neural circuits underlying tianeptine's antidepressant effects. We show that tianeptine induces rapid antidepressant-like effects in mice after as little as one week of treatment. Critically, we also demonstrate that tianeptine's mechanism of action is distinct from fluoxetine in two important aspects: (1) tianeptine requires MORs for its chronic antidepressant-like effect, while fluoxetine does not, and (2) unlike fluoxetine, tianeptine does not promote hippocampal neurogenesis. Using cell-type specific MOR knockouts we further show that MOR expression on GABAergic cells-specifically somatostatin-positive neurons-is necessary for the acute and chronic antidepressant-like responses to tianeptine. Using central infusion of tianeptine, we also implicate the ventral hippocampus as a potential site of antidepressant action. Moreover, we show a dissociation between the antidepressant-like phenotype and other opioid-like phenotypes resulting from acute tianeptine administration such as analgesia, conditioned place preference, and hyperlocomotion. Taken together, these results suggest a novel entry point for understanding what circuit dysregulations may occur in depression, as well as possible targets for the development of new classes of antidepressant drugs.


Assuntos
Receptores Opioides mu , Tiazepinas , Analgésicos Opioides/farmacologia , Animais , Antidepressivos/farmacologia , Fluoxetina/farmacologia , Hipocampo , Humanos , Interneurônios , Camundongos , Receptores Opioides mu/agonistas , Tiazepinas/farmacologia
2.
Neuropsychopharmacology ; 42(10): 2052-2063, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28303899

RESUMO

Depression is a debilitating chronic illness that affects around 350 million people worldwide. Current treatments, such as selective serotonin reuptake inhibitors, are not ideal because only a fraction of patients achieve remission. Tianeptine is an effective antidepressant with a previously unknown mechanism of action. We recently reported that tianeptine is a full agonist at the mu opioid receptor (MOR). Here we demonstrate that the acute and chronic antidepressant-like behavioral effects of tianeptine in mice require MOR. Interestingly, while tianeptine also produces many opiate-like behavioral effects such as analgesia and reward, it does not lead to tolerance or withdrawal. Furthermore, the primary metabolite of tianeptine (MC5), which has a longer half-life, mimics the behavioral effects of tianeptine in a MOR-dependent fashion. These results point to the possibility that MOR and its downstream signaling cascades may be novel targets for antidepressant drug development.


Assuntos
Antidepressivos Tricíclicos/farmacologia , Receptores Opioides mu/metabolismo , Tiazepinas/farmacologia , Analgésicos Opioides/farmacologia , Animais , Antidepressivos Tricíclicos/metabolismo , Antidepressivos Tricíclicos/farmacocinética , Transtorno Depressivo/tratamento farmacológico , Transtorno Depressivo/metabolismo , Relação Dose-Resposta a Droga , Tolerância a Medicamentos , Células HEK293 , Humanos , Masculino , Camundongos Endogâmicos C57BL , Camundongos Knockout , Estrutura Molecular , Morfina/farmacologia , Receptores Opioides mu/agonistas , Receptores Opioides mu/genética , Tiazepinas/metabolismo , Tiazepinas/farmacocinética
3.
Blood ; 118(6): 1653-62, 2011 Aug 11.
Artigo em Inglês | MEDLINE | ID: mdl-21680799

RESUMO

When Glu-plasminogen binds to cells, its activation to plasmin is markedly enhanced compared with the reaction in solution, suggesting that Glu-plasminogen on cell surfaces adopts a conformation distinct from that in solution. However, direct evidence for such conformational changes has not been obtained. Therefore, we developed anti-plasminogen mAbs to test the hypothesis that Glu-plasminogen undergoes conformational changes on its interaction with cells. Six anti-plasminogen mAbs (recognizing 3 distinct epitopes) that preferentially recognized receptor-induced binding sites (RIBS) in Glu-plasminogen were obtained. The mAbs also preferentially recognized Glu-plasminogen bound to the C-terminal peptide of the plasminogen receptor, Plg-R(KT), and to fibrin, plasmin-treated fibrinogen, and Matrigel. We used trypsin proteolysis, immunoaffinity chromatography, and tandem mass spectrometry and identified Glu-plasminogen sequences containing epitopes recognized by the anti-plasminogen-RIBS mAbs: a linear epitope within a domain linking kringles 1 and 2; a nonlinear epitope contained within the kringle 5 domain and the latent protease domain; and a nonlinear epitope contained within the N-terminal peptide of Glu-plasminogen and the latent protease domain. Our results identify neoepitopes latent in soluble Glu-plasminogen that become available when Glu-plasminogen binds to cells and demonstrate that binding of Glu-plasminogen to cells induces a conformational change in Glu-plasminogen distinct from that of Lys-Pg.


Assuntos
Anticorpos Monoclonais/metabolismo , Epitopos/metabolismo , Plasminogênio/metabolismo , Receptores de Superfície Celular/metabolismo , Sequência de Aminoácidos , Anticorpos Monoclonais/imunologia , Sítios de Ligação , Western Blotting , Colágeno/imunologia , Colágeno/metabolismo , Combinação de Medicamentos , Ensaio de Imunoadsorção Enzimática , Epitopos/imunologia , Fibrina/imunologia , Fibrina/metabolismo , Fibrinogênio/imunologia , Fibrinogênio/metabolismo , Humanos , Kringles , Laminina/imunologia , Laminina/metabolismo , Modelos Moleculares , Dados de Sequência Molecular , Fragmentos de Peptídeos/imunologia , Fragmentos de Peptídeos/metabolismo , Plasminogênio/química , Plasminogênio/imunologia , Ligação Proteica , Conformação Proteica , Proteoglicanas/imunologia , Proteoglicanas/metabolismo , Receptores de Superfície Celular/química , Receptores de Superfície Celular/imunologia , Solubilidade , Espectrometria de Massas em Tandem , Células U937
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...